Skip to main content
BLTE logo
BLTE
(NASDAQ)
Belite Bio, Inc
$143.36-- (--)
Loading... - Market loading

Belite Bio (BLTE) Stock Price & Financial Analysis

Belite Bio Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$135.80 - $148.61
52-Week High$200.00
52-Week Low$56.10
Open$142.02
Volume251.00K
Average Volume (3M)129.48K
Market Cap4.69B
Shares Outstanding33.54M
Price to Book (P/B)6.08
EV/EBITDA-55.91
50-Day MA$163.33
200-Day MA$128.43
52-Week Change145.15%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Belite Bio

What is the current stock price for BLTE?

As of the latest trading session, BLTE stock trades at $143.36. The 52-week range is $56.10–$200.00, with a day range of $135.80–$148.60.

What is the P/E ratio for BLTE?

The P/E ratio (Price-to-Earnings) for BLTE is shown in the Key Statistics section. This valuation metric helps compare Belite Bio, Inc to industry peers.

Does BLTE pay dividends?

Belite Bio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BLTE?

Based on 3 analysts, the consensus for BLTE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BLTE?

Belite Bio's market capitalization is $4.81B, classifying it as a mid-cap company. Belite Bio operates in the Healthcare sector within the Biotechnology industry.